Love Ted W's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Sep 2, 2026
- Accession no.
- 0001188919-26-000015
- Filed
- Sep 2, 2026, 5:28 PM ET
- Trade date
- Aug 31, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Love Ted WCIK 0001188919 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Ordinary Shares | FTax withholdingDisposed | −6 | $244.06 | −$1,464.38 | 3,126 | Direct | |
| Aug 31, 2026 | Ordinary Shares | FTax withholdingDisposed | −737 | $241.39 | −$177,904.36 | 2,389 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.